Product information

From Health Canada

No match found

No other product was found with the same active ingredient group.

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2018-07-24

Original market date: See footnote 1

1954-12-31

Product name:

MYLERAN

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

00004618

Product Monograph/Veterinary Labelling:

Date: 2021-02-01 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

ASPEN PHARMACARE CANADA INC.
Unit 8, 1155 North Service Road West
Oakville
Ontario
Canada L6M 3E3

Class:

Human

Dosage form(s):

Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

10:00.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

L01AB01 BUSULFAN

Active ingredient group (AIG) number:See footnote5

0103273001

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
BUSULFAN 2 MG
Version 4.0.3

"Page details"

Date modified: